Real-time enrollment status for this castration-resistant prostate carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:53 PM UTC
| NCT Number | NCT05805371 |
| Recruiting Status | Recruiting |
| Condition | Castration-Resistant Prostate Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 21 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | November 19, 2025 (Nov 19, 2025) |
As of July 17, 2026: Clinical trial NCT05805371 is currently recruiting participants. This phase1 study for castration-resistant prostate carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05805371 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05805371 was last updated Nov 19, 2025 (November 19, 2025). HelloStudys verifies this status automatically.